Wyoming Healthcare Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Healthcare Weekly.

Press releases published on September 30, 2026

2 hours ago

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Oculis Announces Resignation of Lionel Carnot from Board of Directors

Indeterminate GlobeNewswire

2 hours ago

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference

Indeterminate GlobeNewswire

3 hours ago

Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

3 hours ago

Standard BioTools Provides Update on Sale of Mass Cytometry Business

Indeterminate GlobeNewswire

3 hours ago

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness

Indeterminate GlobeNewswire

3 hours ago

Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements

Indeterminate GlobeNewswire

4 hours ago

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

4 hours ago

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

4 hours ago

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

4 hours ago

Longeveron to Participate in Three Longevity/Aging Investment Conferences

Indeterminate GlobeNewswire

4 hours ago

Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

4 hours ago

Scienture Holdings, Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

4 hours ago

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

Indeterminate GlobeNewswire

4 hours ago

Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk

Indeterminate GlobeNewswire

5 hours ago

Type 2 Diabetes Doesn’t Have to Be Your Future: Medicare Has a Benefit That Can Help

Indeterminate GlobeNewswire

5 hours ago

COBRA Alternatives After Job Loss: How Healthcare Sharing Membership Works

Indeterminate GlobeNewswire

6 hours ago

A Pattern of Progress: TriHex™ is Reshaping Back-Of-Hand Protection

Indeterminate GlobeNewswire

6 hours ago

NewGen Announces Closing of $1.25 Million Public Offering

Indeterminate GlobeNewswire

6 hours ago

Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor

Indeterminate GlobeNewswire